Filing Details
- Accession Number:
- 0001127602-22-016032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-31 17:13:36
- Reporting Period:
- 2022-05-26
- Accepted Time:
- 2022-05-31 17:13:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1518973 | Michel Lagarde | 168 Third Avenue Waltham MA 02451 | Executive Vice President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-26 | 6,049 | $210.68 | 21,807 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-05-26 | 10,715 | $253.99 | 32,522 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-05-26 | 7,542 | $535.38 | 24,980 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-26 | 7,083 | $536.25 | 17,897 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-26 | 2,139 | $537.40 | 15,758 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-05-27 | 9,137 | $309.63 | 24,895 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-05-27 | 3,893 | $458.81 | 28,788 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-05-27 | 3,117 | $564.23 | 25,671 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-27 | 8,731 | $565.18 | 16,940 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-27 | 1,182 | $566.16 | 15,758 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-05-26 | 10,715 | $0.00 | 10,715 | $253.99 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-05-26 | 6,049 | $0.00 | 6,049 | $210.68 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-05-27 | 3,893 | $0.00 | 3,893 | $458.81 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-05-27 | 9,137 | $0.00 | 9,137 | $309.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,638 | 2026-02-26 | No | 4 | M | Direct | |
0 | 2025-02-27 | No | 4 | M | Direct | |
11,682 | 2028-02-23 | No | 4 | M | Direct | |
9,138 | 2027-02-25 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.86 to $535.85, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), and (6) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.86 to $536.85, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.86 to $537.59, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.695 to $564.69, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.70 to $565.69, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.815 to $566.71, inclusive.
- The option vests in four equal annual installments. One-quarter of the shares vested on February 26, 2020, 2021 and 2022 and the remaining one-quarter will vest on February 26, 2023.
- The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022.
- The option vests in four equal annual installments. One-quarter of the shares vested on February 23, 2022, and the remaining three quarters will vest on February 23, 2023, 2024 and 2025.
- The option vests in four equal annual installments. One-quarter of the shares vested on February 25, 2021 and 2022, and the remaining two quarters will vest on February 25, 2023 and 2024.